BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11450259)

  • 1. Serum amyloid A peptide interactions with glycosaminoglycans. Evaluation by affinity chromatography.
    Ancsin JB; Kisilevsky R
    Methods Mol Biol; 2001; 171():449-56. PubMed ID: 11450259
    [No Abstract]   [Full Text] [Related]  

  • 2. Human serum amyloid P component binds to a specific peptide in the presence of calcium.
    Hamazaki H
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1172-8. PubMed ID: 7802647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
    Wang L; Lashuel HA; Colón W
    Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of serum amyloid A protein in the rabbit: comparison with serum amyloid A proteins in other species.
    Liepnieks JJ; Dwulet FE; Benson MD; Kluve-Beckerman B; Kushner I
    J Lab Clin Med; 1991 Dec; 118(6):570-5. PubMed ID: 1744506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
    Ancsin JB; Kisilevsky R
    J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for serum amyloid A amyloidosis.
    Kindy MS; de Beer FC
    Methods Enzymol; 1999; 309():701-16. PubMed ID: 10507056
    [No Abstract]   [Full Text] [Related]  

  • 7. Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A.
    Ancsin JB; Kisilevsky R
    Amyloid; 1999 Mar; 6(1):37-47. PubMed ID: 10211410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The competition of serum amyloid protein and apoprotein E for binding with human serum albumin].
    Dergunov AD
    Biull Eksp Biol Med; 1992 Dec; 114(12):598-600. PubMed ID: 1292684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
    Kisilevsky R
    Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for amyloid-binding proteins by affinity chromatography.
    Calero M; Rostagno A; Ghiso J
    Methods Mol Biol; 2012; 849():213-23. PubMed ID: 22528093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
    Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
    Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between apolipoprotein serum amyloid A and high-density lipoprotein.
    Wang L; Colón W
    Biochem Biophys Res Commun; 2004 Apr; 317(1):157-61. PubMed ID: 15047161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
    Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
    Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A: a typical acute-phase reactant in rainbow trout?
    Villarroel F; Casado A; Vásquez J; Matamala E; Araneda B; Amthauer R; Enriquez R; Concha MI
    Dev Comp Immunol; 2008; 32(10):1160-9. PubMed ID: 18440634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.
    Karr JW; Szalai VA
    J Am Chem Soc; 2007 Apr; 129(13):3796-7. PubMed ID: 17352478
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies.
    Gandhi NS; Coombe DR; Mancera RL
    Biochemistry; 2008 Apr; 47(17):4851-62. PubMed ID: 18393439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.